ELMIRON® is a prescription medicine used to treat bladder pain or discomfort associated with interstitial cystitis. It is not known if ELMIRON® is safe and effective in children under 16 years of age.
Serious side effects have been reported with the use of ELMIRON®, including:
Throughout your treatment, regular eye examinations that include retinal examinations are suggested for early detection of retinal/macular changes. Your doctor will discuss with you when to get your first eye examination and follow up exams, and whether the treatment should be continued.
Your risk of bleeding may be increased if you take ELMIRON® along with other medicines such as:
Tell your healthcare provider if you are taking any of these medicines.
Tell your healthcare provider if you are going to have surgery. Your healthcare provider may stop ELMIRON® before you have surgery.
Talk to your healthcare provider about when to stop taking ELMIRON® and when to start taking it again.
What should I tell my healthcare provider before taking ELMIRON®?
Tell your healthcare provider if you:
What are the possible side effects of ELMIRON®?
ELMIRON® may cause serious side effects including:
See “What is the most important information I should know about ELMIRON® (pentosan polysulfate sodium) Capsules?”
The most common side effects of ELMIRON® are:
These are not all the possible side effects of ELMIRON®.
Call your doctor for medical advice about side effects. You are also encouraged to report side effects to the FDA: visit http://www.fda.gov/medwatch or call 1‑800‑FDA‑1088. You may also report side effects to Janssen Pharmaceuticals, Inc., at 1‑800‑JANSSEN (1‑800‑526‑7736).
How should I store ELMIRON®?
How should I take ELMIRON®?
Please click here to see full Prescribing Information and read the Medication Guide.
cp-11575v5
ELMIRON® is a prescription medicine used to treat bladder pain or discomfort associated with interstitial cystitis. It is not known if ELMIRON® is safe and effective in children under 16 years of age.
Serious side effects have been reported with the use of ELMIRON®, including:
Throughout your treatment, regular eye examinations that include retinal examinations are suggested for early detection of retinal/macular changes. Your doctor will discuss with you when to get your first eye examination and follow up exams, and whether the treatment should be continued.
Your risk of bleeding may be increased if you take ELMIRON® along with other medicines such as:
Tell your healthcare provider if you are taking any of these medicines.
Tell your healthcare provider if you are going to have surgery. Your healthcare provider may stop ELMIRON® before you have surgery.
Talk to your healthcare provider about when to stop taking ELMIRON® and when to start taking it again.
What should I tell my healthcare provider before taking ELMIRON®?
Tell your healthcare provider if you:
What are the possible side effects of ELMIRON®?
ELMIRON® may cause serious side effects including:
See “What is the most important information I should know about ELMIRON® (pentosan polysulfate sodium) Capsules?”
The most common side effects of ELMIRON® are:
These are not all the possible side effects of ELMIRON®.
Call your doctor for medical advice about side effects. You are also encouraged to report side effects to the FDA: visit http://www.fda.gov/medwatch or call 1‑800‑FDA‑1088. You may also report side effects to Janssen Pharmaceuticals, Inc., at 1‑800‑JANSSEN (1‑800‑526‑7736).
How should I store ELMIRON®?
How should I take ELMIRON®?
Please click here to see full Prescribing Information and read the Medication Guide.
cp-11575v5